Company Filing History:
2 out of 3 
1 out of 2 Years Active: 2011-2016
Title: Di Xiang: Innovator in Medical Treatments
Introduction
Di Xiang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical treatments, particularly in the area of gastrointestinal health and hematopoietic recovery. With a total of 3 patents, his work focuses on innovative methods that utilize interleukin-1 receptor antagonists.
Latest Patents
One of Di Xiang's latest patents is titled "Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist." This invention provides a use of the interleukin-1 receptor antagonist protein for preparing a medicament aimed at preventing or treating epithelium trauma of the intestinal mucosa. The protein can either have a specific amino acid sequence or possess at least 70% homology with that sequence, ensuring its effectiveness in treating such conditions. Another notable patent is "Methods of using interleukin-1 receptor antagonist as a myeloprotective agent." This invention relates to the use of interleukin-1 receptor antagonist (IL-1Ra) in promoting bone marrow regeneration and alleviating hematopoietic toxicities associated with chemotherapy.
Career Highlights
Throughout his career, Di Xiang has worked with various organizations, including General Regeneratives Ltd. and General Regeneratives Holdings Inc. His innovative approaches have garnered attention in the medical community, leading to advancements in treatment methodologies.
Collaborations
Di Xiang has collaborated with notable colleagues such as Wei Han and Jing Jing Zhang. Their combined expertise has contributed to the development of groundbreaking medical solutions.
Conclusion
Di Xiang's work exemplifies the impact of innovation in medicine, particularly through his patents that address critical health issues. His contributions continue to pave the way for advancements in treatment options for patients worldwide.